CA3169155C - Anticorps anti-cd19 humain - Google Patents

Anticorps anti-cd19 humain

Info

Publication number
CA3169155C
CA3169155C CA3169155A CA3169155A CA3169155C CA 3169155 C CA3169155 C CA 3169155C CA 3169155 A CA3169155 A CA 3169155A CA 3169155 A CA3169155 A CA 3169155A CA 3169155 C CA3169155 C CA 3169155C
Authority
CA
Canada
Prior art keywords
seq
antibody
human
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3169155A
Other languages
English (en)
Other versions
CA3169155A1 (fr
Inventor
Barrett Allan
Jeffrey Streetman Boyles
Alison Lee Sim Budelsky
Songqing Na
Kira Vladimirovna Rubtsova
Guifeng ZHANG
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Priority claimed from PCT/US2021/018989 external-priority patent/WO2021173471A1/fr
Publication of CA3169155A1 publication Critical patent/CA3169155A1/fr
Application granted granted Critical
Publication of CA3169155C publication Critical patent/CA3169155C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des anticorps qui se lient au CD19 humain (anticorps anti-CD19 humain ou anticorps anti-CD19 humain), des compositions comprenant de tels anticorps anti-CD19 humain et des procédés d'utilisation de tels anticorps anti-CD19 humain.
CA3169155A 2020-02-28 2021-02-22 Anticorps anti-cd19 humain Active CA3169155C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062983093P 2020-02-28 2020-02-28
US62/983,093 2020-02-28
PCT/US2021/018989 WO2021173471A1 (fr) 2020-02-28 2021-02-22 Anticorps anti-cd19 humain

Publications (2)

Publication Number Publication Date
CA3169155A1 CA3169155A1 (fr) 2021-09-02
CA3169155C true CA3169155C (fr) 2025-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
US11623956B2 (en) Anti-human CD19 antibodies
CN111886253B (zh) Pd-1激动剂抗体及其用途
CN105026428B (zh) PD‑l抗体、其抗原结合片段及其医药用途
EP4347655A1 (fr) Anticorps anti-ccr8 et leurs utilisations
CA3155275A1 (en) Anti-cd47 antibodies and methods of use thereof
CN112969714A (zh) 抗cd40抗体、其抗原结合片段及其医药用途
JP2026021532A (ja) Ｂｔｌａ抗体
CN108473586B (zh) 抗cd27抗体、其抗原结合片段及其医药用途
JP2023537331A (ja) Ｃｄ４７抗体及びその応用
CA3169155C (fr) Anticorps anti-cd19 humain
EA048769B1 (ru) Антитела к cd19 человека
RU2779128C2 (ru) Антитело к cd40, его антигенсвязывающий фрагмент и его медицинское применение
US20240166745A1 (en) Lag-3 and pd-1/lag-3-antibodies
WO2021175954A1 (fr) Anticorps ayant une spécificité pour btnl8 et leurs utilisations
HK40051457A (en) Anti-cd40 antibody, antigen binding fragment and pharmaceutical use thereof